Muscular Dystrophy Association Research Grant for the HEALEY ALS Platform Trial
MDA Awards $500,000 Grant to Accelerate ALS Research Through the HEALEY ALS Platform Trial at Massachusetts General Hospital
September 19, 2024 09:00 ET | Muscular Dystrophy Association
New York, Sept. 19, 2024 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) is proud to announce a new clinical research grant of $500,000 over three years, awarded to Sabrina Paganoni,...
MDA's #30DaysOfStrength Campaign for Muscular Dystrophy Awareness Month in September
MDA Kicks Off Muscular Dystrophy Awareness Month in September with ‘30 Days of Strength’ Campaign with Hundreds of Events to Advance Research and Care for the Neuromuscular Disease Community
August 26, 2024 08:58 ET | Muscular Dystrophy Association
New York, Aug. 26, 2024 (GLOBE NEWSWIRE) -- September marks the kick-off of the Muscular Dystrophy Association (MDA) ‘National Muscular Dystrophy Awareness Month’ to raise awareness and critical...
IAFF Fill the Boot Labor Day Weekend
Muscular Dystrophy Association International Association of Fire Fighters Launch 420 Fill the Boot Fundraisers in Cities Across America Labor Day Weekend for the Muscular Dystrophy Association
August 19, 2024 09:15 ET | Muscular Dystrophy Association
New York, Aug. 19, 2024 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) in partnership with the International Association of Fire Fighters (IAFF) kick off more than 420 Fill the Boot...
End ALS with Muscular Dystrophy Association
Muscular Dystrophy Association’s Impact to End ALS Continues with Fourth Annual Lou Gehrig Day at Major League Baseball Games
May 21, 2024 09:07 ET | Muscular Dystrophy Association
New York, May 21, 2024 (GLOBE NEWSWIRE) -- Muscular Dystrophy Association (MDA) is gathering its extended community at Major League Baseball (MLB) parks across the United States, uniting ALS...
End ALS with Muscular Dystrophy Association
Muscular Dystrophy Association Launches ALS Awareness Month with Public Service Announcement ‘Answering the Call’
April 29, 2024 09:00 ET | Muscular Dystrophy Association
New York, April 29, 2024 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) today announced programming and fundraising events in support of people living with Amyotrophic Lateral...
Muscular Dystrophy Association Celebrates 70 Years of Partnership with International Association of Fire Fighters
International Association of Fire Fighters & Affiliates Launch ‘Fill the Boot’ Fundraisers Nationwide for Muscular Dystrophy Association
April 10, 2024 09:00 ET | Muscular Dystrophy Association
New York, April 10, 2024 (GLOBE NEWSWIRE) -- Muscular Dystrophy Association (MDA) celebrates 70 years of partnership with the International Association of Fire Fighters (IAFF) kicking off more...
July 30, 2021 - ROSEN LOGO.jpg
AMLX DEADLINE TOMORROW: ROSEN, LEADING INVESTOR COUNSEL, Encourages Amylyx Pharmaceuticals, Inc. Investors to Secure Counsel Before Important April 9 Deadline in Securities Class Action – AMLX
April 08, 2024 10:04 ET | The Rosen Law Firm PA
NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) between...
NFL Running Back Nyheim Hines Supports Nation's Largest St. Patrick’s Day Fundraising Campaign to Benefit Muscular Dystrophy Association
NFL Running Back Nyheim Hines Supports Nation's Largest St. Patrick’s Day Fundraising Campaign to Benefit Muscular Dystrophy Association
March 13, 2024 09:00 ET | Muscular Dystrophy Association
New York, March 13, 2024 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) today announced its continued partnership with Nyheim Hines -- an NFL running back who has agreed to a new...
retro.jpg
Retrotope Announces Completion of Enrollment in Phase 2 Study of RT001 in Patients with Amyotrophic Lateral Sclerosis (ALS)
April 21, 2021 07:00 ET | Retrotope
LOS ALTOS, Calif., April 21, 2021 (GLOBE NEWSWIRE) -- Retrotope, a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class therapies for degenerative diseases,...
retro.jpg
Retrotope Announces Initiation of Phase 2 Study of RT001 in Patients with Amyotrophic Lateral Sclerosis (ALS)
March 17, 2021 07:00 ET | Retrotope
LOS ALTOS, Calif., March 17, 2021 (GLOBE NEWSWIRE) -- Retrotope, a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class therapies for degenerative diseases,...